Bionano Genomics, Inc. (BNGO)
1.65
+0.01
(+0.61%)
USD |
NASDAQ |
Dec 09, 15:04
Bionano Genomics Shareholders Equity (Quarterly): 49.80M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp. | 2.432B |
| Azenta, Inc. | 1.727B |
| Harvard Bioscience, Inc. | 14.07M |
| Precipio, Inc. | 13.75M |
| Kestra Medical Technologies Ltd. | 184.16M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 79.06M |
| Total Liabilities (Quarterly) | 29.26M |
| Debt to Equity Ratio | 0.3453 |
| Current Ratio | 2.124 |
| Net Debt Paydown Yield | 12.47% |